|
⚲
|
| Scolr Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000934936 |
| Sale | 2010-03-04 ($4.1 M Offered, $4.1 M Sold) |
| Fund | |
| Phone | 4253681050 |
| Address | 19204 North Creek Parkway Bothell, 98011 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Randall Caudill | |
| Herbert Lucas | |
| Michael Taglich | |
| Bruce Morra | |
| Jeffrey Reich | |
| Richard Levy | |
| Stephen Turner |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Haynie James P.
✚
|
0.0 | |
|
Hays Ed
✚
|
0.0 | |
|
Hays J Robison III
✚
|
0.0 | |
|
Hays Michael D.
✚
|
0.0 | |
|
Haystack Investment Fund LP
✚
|
0.0 | |
|
Hayes Barbara A
✚
|
0.0 | |
|
Hayes Christopher G.
✚
|
0.0 | |
|
Hayes James S
✚
|
0.0 | |
|
Hayes Jerald Benjamin
✚
|
0.0 | |
|
Haynes Morgan Tarazeta J
✚
|
0.0 |